However, ERBB2 status in patients with single hormone receptor–positive BC in our analysis was consistent with that reported in a study27 with a large sample size, which showed that ERBB2 status differed statistically significantly among the 4 subtypes. This evidence concerns the gene ERBB2 and breast cancer.